The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease
暂无分享,去创建一个
I. Gussak | B. Williams | W. Ebling | H. Pieniaszek | S. Kopecky | R. Wright | S. Sy | Joseph G. Murphy | V. Cain | R. Daly | Kristen Simonson | R. A. Wilcox | J. Murphy